Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

Description

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Conditions

Outpatient Prescription Issues

Talk to us

Study Overview

On this page

Study Details

Study overview

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues: a Descriptive Study

Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

Condition
Outpatient Prescription Issues
Intervention / Treatment

-

Contacts and Locations

Dallas

Clinical Research Institute at Methodist Health System, Dallas, Texas, United States, 75203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.
  • * CPA actions were misclassified as discharge prescription issue resolutions.
  • * Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
  • * Patients documented to have left the ED against medical advice.

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Methodist Health System,

Kevin Burnham, Pharm.D., PRINCIPAL_INVESTIGATOR, Methodist Health System

Study Record Dates

2026-12-15